At ITAAN PHARMA, pharmacy professionals are at the helm, shaping a future where innovation, precision, and compliance define us. Our leadership team brings decades of specialized experience in sterile product development and commercialization, ensuring that every aspect of our operations aligns with the latest global regulatory requirements – from early-phase formulation to regulatory submission and commercial-scale manufacturing. Our unwavering commitment to scientific rigor and attention to product-specific details enables us to develop high-quality injectable therapies that meet critical patient needs. We optimize the product lifecycle by integrating technical expertise with strategic commercialization, ensuring efficiency, scalability, and market success.

Our leadership's expertise includes:

• Niche Injectable & 505(b)(2) Development – Developed complex and differentiated formulations for highly regulated markets, addressing unmet clinical needs.
• Global Regulatory Compliance – Successfully navigated regulatory submissions and site inspections from the U.S. FDA, Health Canada, EMA and other regulators.
• cGMP Manufacturing at Scale – Operated and optimized high-volume sterile manufacturing facilities, leveraging process controls for efficiency and consistency.
• Industry Thought Leadership – Contributed to key pharmaceutical industry guidelines through PDA, ISPE, RAPS and AAPS, reinforcing best practices in injectable drug manufacturing.

At ITAAN PHARMA, we don't just develop and manufacture injectables – we set new benchmarks in innovation, quality, and compliance to drive the future of sterile pharmaceuticals.